Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 75 articles: HTML format

Single Articles

August 2008
1. YOSHIMOTO M , Ogawa K, Washiyama K, Shikano N, et al
   alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
   Int J Cancer. 2008;123:709-15.
   PubMed     Related articles    Abstract available
   
   
   July 2008
2. YANG JL , Qu XJ, Yu Y, Kohn EC, et al
   Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
   Int J Cancer. 2008;123:258-63.
   PubMed     Related articles    Abstract available
   
   
   
3. VAN DER GUN BT , Wasserkort R, Monami A, Jeltsch A, et al
   Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
   Int J Cancer. 2008;123:484-9.
   PubMed     Related articles    Abstract available
   
   
   June 2008
4. GHADERSOHI A , Odunsi K, Zhang S, Azrak RG, et al
   Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. KUBLER K , Arndt PF, Wardelmann E, Landwehr C, et al
   Genetic alterations of HLA-class II in ovarian cancer.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. WITHAM J , Vidot S, Agarwal R, Kaye SB, et al
   Transient ectopic expression as a method to detect genes conferring drug resistance.
   Int J Cancer. 2008;122:2641-5.
   PubMed     Related articles    Abstract available
   
   
   May 2008
7. HUANG RY , Wang SM, Hsieh CY, Wu JC, et al
   Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. YANG L , Klint A, Lambe M, Bellocco R, et al
   Predictors of ovarian cancer survival: A population-based prospective study in Sweden.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. ROSSI M , Negri E, Lagiou P, Talamini R, et al
   Flavonoids and ovarian cancer risk: A case-control study in Italy.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. FIEGL H , Windbichler G, Mueller-Holzner E, Goebel G, et al
    HOXA11 DNA methylation-A novel prognostic biomarker in ovarian cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. MALEK A , Bakhidze E, Noske A, Sers C, et al
    HMGA2 gene is a promising target for ovarian cancer silencing therapy.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
12. OLSEN CM , Nagle CM, Whiteman DC, Purdie DM, et al
    Body size and risk of epithelial ovarian and related cancers: A population-based case-control study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. RAMUS SJ , Vierkant RA, Johnatty SE, Pike MC, et al
    Consortium analysis of 7 candidate SNPs for ovarian cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. QUAN H , Xu Y, Lou L
    p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.
    Int J Cancer. 2008;122:1730-7.
    PubMed     Related articles    Abstract available
    
    
    
15. LIAO X , Siu MK, Chan KY, Wong ES, et al
    Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. WATSON P , Vasen HF, Mecklin JP, Bernstein I, et al
    The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
17. GREGORY-BASS RC , Olatinwo M, Xu W, Matthews R, et al
    Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
18. VARTIAINEN J , Lassus H, Lehtovirta P, Finne P, et al
    Combination of serum hCGbeta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. CHAUDHRY P , Srinivasan R, Patel FD, Gopalan S, et al
    Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
20. JORDAN SJ , Green AC, Whiteman DC, Moore SP, et al
    Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. SHAW TJ , Lacasse EC, Durkin JP, Vanderhyden BC, et al
    Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
22. VERKOOIJEN HM , Fioretta G, Rapiti E, Vlastos G, et al
    Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: Results from a population-based study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. COFFELT SB , Waterman RS, Florez L, Bentrup KH, et al
    Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. FRASER M , Bai T, Tsang BK
    Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. GRAM IT , Braaten T, Adami HO, Lund E, et al
    Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
26. SOLAR P , Feldman L, Jeong JY, Busingye JR, et al
    Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
27. JEONG JY , Feldman L, Solar P, Szenajch J, et al
    Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
28. KAJIYAMA H , Shibata K, Terauchi M, Ino K, et al
    Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
29. DESJARDINS S , Belleau P, Labrie Y, Ouellette G, et al
    Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. EDEFONTI V , Decarli A, Vecchia CL, Bosetti C, et al
    Nutrient dietary patterns and the risk of breast and ovarian cancers.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. MERRITT MA , Green AC, Nagle CM, Webb PM, et al
    Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. LUNDQVIST E , Kaprio J, Verkasalo PK, Pukkala E, et al
    Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins.
    Int J Cancer. 2007;121:810-8.
    PubMed     Related articles    Abstract available
    
    
    
33. GALLUS S , Scotti L, Talamini R, Franceschi S, et al
    Reply to: Alcohol consumption and ovarian cancer risk in a population-based case-control study by Peterson et al.
    Int J Cancer. 2007;.
    PubMed     Related articles   
    
    
    
34. LAMBECK A , Leffers N, Hoogeboom BN, Sluiter W, et al
    P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy.
    Int J Cancer. 2007;121:606-14.
    PubMed     Related articles    Abstract available
    
    
    July 2007
35. WANG-JOHANNING F , Huang M, Liu J, Rycaj K, et al
    Sheep stromal-epithelial cell interactions and ovarian tumor progression.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. BERMEJO-PEREZ MJ , Marquez-Calderon S, Llanos-Mendez A
    Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review.
    Int J Cancer. 2007;121:225-31.
    PubMed     Related articles    Abstract available
    
    
    June 2007
37. WEISS JM , Huang WY, Rinaldi S, Fears TR, et al
    IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. YOKOYAMA Y , Ramakrishnan S
    Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. NAKAYAMA K , Nakayama N, Jinawath N, Salani R, et al
    Amplicon profiles in ovarian serous carcinomas.
    Int J Cancer. 2007;120:2613-7.
    PubMed     Related articles    Abstract available
    
    
    
40. DEVALAPALLY H , Duan Z, Seiden MV, Amiji MM, et al
    Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. KENNY HA , Krausz T, Yamada SD, Lengyel E, et al
    Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. PIZARRO GO , Zhou XC, Koch A, Gharib M, et al
    Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse.
    Int J Cancer. 2007;120:2339-43.
    PubMed     Related articles    Abstract available
    
    
    May 2007
43. LANE D , Robert V, Grondin R, Rancourt C, et al
    Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. YAMASHITA M , Kajiyama H, Terauchi M, Shibata K, et al
    Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
    Int J Cancer. 2007;120:2243-50.
    PubMed     Related articles    Abstract available
    
    
    
45. LI P , Maines-Bandiera S, Kuo WL, Guan Y, et al
    Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression.
    Int J Cancer. 2007;120:1863-73.
    PubMed     Related articles    Abstract available
    
    
    April 2007
46. GATES MA , Tworoger SS, Hecht JL, De Vivo I, et al
    A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
47. SZLOSAREK PW , Grimshaw MJ, Wilbanks GD, Hagemann T, et al
    Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. OEI AL , Verheijen RH, Seiden MV, Benigno BB, et al
    Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
49. BLOOM GC , Eschrich S, Zhou JX, Coppola D, et al
    Elucidation of a protein signature discriminating six common types of adenocarcinoma.
    Int J Cancer. 2007;120:769-75.
    PubMed     Related articles    Abstract available
    
    
    
50. LIM R , Ahmed N, Borregaard N, Riley C, et al
    Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. REIMER D , Steppan I, Wiedemair A, Concin N, et al
    Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. DIJKGRAAF I , Kruijtzer JA, Frielink C, Corstens FH, et al
    Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
    Int J Cancer. 2007;120:605-10.
    PubMed     Related articles    Abstract available
    
    
    January 2007
53. FENG W , Lu Z, Luo RZ, Zhang X, et al
    Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
54. TAKEI Y , Mizukami H, Saga Y, Yoshimura I, et al
    Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
55. KUBLER K , Arndt PF, Wardelmann E, Krebs D, et al
    HLA-class II haplotype associations with ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
56. WANG-JOHANNING F , Liu J, Rycaj K, Huang M, et al
    Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
57. MASCARENHAS C , Lambe M, Bellocco R, Bergfeldt K, et al
    Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. RASHID MU , Zaidi A, Torres D, Sultan F, et al
    Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
59. PETERSON NB , Trentham-Dietz A, Newcomb PA, Chen Z, et al
    Alcohol consumption and ovarian cancer risk in a population-based case-control study.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. YANG H , He L, Kruk P, Nicosia SV, et al
    Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
61. STEFFEN J , Nowakowska D, Niwinska A, Czapczak D, et al
    Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
    Int J Cancer. 2006;119:472-5.
    PubMed     Related articles    Abstract available
    
    
    
62. JEKERLE V , Klinkhammer W, Scollard DA, Breitbach K, et al
    In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Int J Cancer. 2006;119:414-22.
    PubMed     Related articles    Abstract available
    
    
    
63. OUELLET V , Page CL, Guyot MC, Lussier C, et al
    SET complex in serous epithelial ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. KOUSHIK A , Hunter DJ, Spiegelman D, Anderson KE, et al
    Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
65. ALDOVINI D , Demichelis F, Doglioni C, Di Vizio D, et al
    M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
66. SILLANPAA SM , Anttila MA, Voutilainen KA, Ropponen KM, et al
    Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
67. TUHKANEN H , Anttila M, Kosma VM, Heinonen S, et al
    Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. OKOCHI-TAKADA E , Nakazawa K, Wakabayashi M, Mori A, et al
    Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
69. GEVAERT O , Pochet N, De Smet F, Van Gorp T, et al
    Molecular profiling of platinum resistant ovarian cancer: Use of the model in clinical practice.
    Int J Cancer. 2006;.
    PubMed     Related articles   
    
    
    
70. HERMSEN BB , van Diest PJ, Berkhof J, Menko FH, et al
    Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
71. OUELLET V , Guyot MC, Le Page C, Filali-Mouhim A, et al
    Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
72. BREWER M , Kirkpatrick ND, Wharton JT, Wang J, et al
    4-HPR modulates gene expression in ovarian cells.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
73. NEWTON TR , Parsons PG, Lincoln DJ, Cummings MC, et al
    Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    February 2006
74. SUI M , Chen F, Chen Z, Fan W, et al
    Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2005
75. ZHU Y , Brannstrom M, Janson PO, Sundfeldt K, et al
    Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours.
    Int J Cancer 2005;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: